IY-828026
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IY-828026, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers [Phase 1]